nivolumab|abdominal discomfort
nivolumab|abdominal pain
nivolumab|abortion
nivolumab|acial and abducens nerve paresis
nivolumab|acneiform dermatitis
nivolumab|acute kidney injury
nivolumab|adrenal insufficiency
nivolumab|allergic dermatitis
nivolumab|anemia
nivolumab|arthralgia
nivolumab|asthenia
nivolumab|asthenic conditions
nivolumab|atopic dermatitis
nivolumab|autoimmune neuropathy
nivolumab|autoimmune thyroiditis
nivolumab|blood tsh decrease
nivolumab|blood tsh increase
nivolumab|bone pain
nivolumab|bronchopneumonia
nivolumab|bullous dermatitis
nivolumab|cardiac disorder
nivolumab|cardiovascular failure
nivolumab|colitis
nivolumab|constipation
nivolumab|cough
nivolumab|death
nivolumab|decreased appetite
nivolumab|demyelination
nivolumab|dermatitis acneiform
nivolumab|dermatitis bullous
nivolumab|dermatitis exfoliative
nivolumab|diabetic ketoacidosis
nivolumab|diarrhea
nivolumab|discomfort
nivolumab|dizziness
nivolumab|drug eruption
nivolumab|duodenitis
nivolumab|dysesthesia
nivolumab|dyspnea
nivolumab|edema
nivolumab|elevated triglycerides
nivolumab|embryo-fetal toxicity
nivolumab|encephalitis
nivolumab|enterocolitis
nivolumab|erythema
nivolumab|erythema multiforme
nivolumab|erythematous rash
nivolumab|eschericia
nivolumab|exertional dyspnea
nivolumab|exfoliative dermatitis
nivolumab|exfoliative rash
nivolumab|extremity pain
nivolumab|face edema
nivolumab|fatal
nivolumab|fatigue
nivolumab|fever
nivolumab|follicular rash
nivolumab|fungal urinary tract infection
nivolumab|gamma-glutamyltransferase increase
nivolumab|gastritis
nivolumab|gastroenteritis
nivolumab|general disorders and administration site conditions
nivolumab|general physical health deterioration
nivolumab|generalized edema
nivolumab|generalized pruritus
nivolumab|generalized rash
nivolumab|gravitational edema
nivolumab|guillain‑barr syndrome
nivolumab|headache
nivolumab|hepatic impairment
nivolumab|hepatic veno-occlusive disease
nivolumab|hepatitis
nivolumab|histiocytic necrotizing lymphadenitis
nivolumab|hyperacute graft-versus-host-disease
nivolumab|hypercalcemia
nivolumab|hyperesthesia
nivolumab|hyperglycemia
nivolumab|hyperkalemia
nivolumab|hyperthyroidism
nivolumab|hypocalcemia
nivolumab|hypoesthesia
nivolumab|hypokalemia
nivolumab|hypomagnesemia
nivolumab|hyponatremia
nivolumab|hypophysitis
nivolumab|hypopituitarism
nivolumab|hypothyroidism
nivolumab|increased alkaline phosphatase
nivolumab|increased alt
nivolumab|increased amylase
nivolumab|increased aspartate aminotransferase
nivolumab|increased ast
nivolumab|increased bilirubin
nivolumab|increased cholesterol
nivolumab|increased creatinine
nivolumab|increased lipase
nivolumab|increased triglycerides
nivolumab|increased tsh
nivolumab|infection
nivolumab|infusion reaction
nivolumab|infusion-related reaction
nivolumab|infusion-related reactions
nivolumab|interstitial lung disease
nivolumab|intestinal perforation
nivolumab|iridocyclitis
nivolumab|iritis
nivolumab|kikuchi lymphadenitis
nivolumab|leucopenia
nivolumab|leukopenia
nivolumab|limbic encephalitis
nivolumab|localized edema
nivolumab|lower and upper abdominal pain
nivolumab|lymphedema
nivolumab|lymphopenia
nivolumab|macular rash
nivolumab|maculopapular rash
nivolumab|malaise
nivolumab|metastatic disease
nivolumab|migraine
nivolumab|morbilliform rash
nivolumab|motor dysfunction
nivolumab|multi-organ failure
nivolumab|musculoskeletal chest pain
nivolumab|musculoskeletal discomfort
nivolumab|musculoskeletal pain
nivolumab|myalgia
nivolumab|myasthenic syndrome
nivolumab|myocarditis
nivolumab|myopathy
nivolumab|myositis
nivolumab|nasal congestion
nivolumab|nasopharyngitis
nivolumab|nausea
nivolumab|neck pain
nivolumab|nephritis
nivolumab|neuritis
nivolumab|neuropathy
nivolumab|neuropathy peripheral
nivolumab|neutropenia
nivolumab|pain
nivolumab|pain in extremity
nivolumab|palmar-plantar erythrodysesthesia
nivolumab|pancreatitis
nivolumab|papulosquamous rash
nivolumab|paresthesia
nivolumab|periorbital edema
nivolumab|peripheral edema
nivolumab|peripheral motor neuropathy
nivolumab|peripheral neuropathy
nivolumab|peripheral sensory neuropathy
nivolumab|peripheral swelling
nivolumab|peroneal nerve palsy
nivolumab|pleural effusion
nivolumab|pneumocystis jirovecii pneumonia
nivolumab|pneumonia
nivolumab|pneumonia bacterial
nivolumab|pneumonia mycoplasmal
nivolumab|pneumonitis
nivolumab|polymyalgia rheumatica
nivolumab|polyneuropathy
nivolumab|productive cough
nivolumab|pruritic rash
nivolumab|pruritus
nivolumab|psoriasiform dermatitis
nivolumab|psoriasis
nivolumab|pulmonary edema
nivolumab|pulmonary embolism
nivolumab|pustular rash
nivolumab|pyrexia
nivolumab|rash
nivolumab|renal dysfunction
nivolumab|renal impairment
nivolumab|respiratory failure
nivolumab|respiratory tract infection
nivolumab|rhabdomyolysis
nivolumab|rhinitis
nivolumab|sarcoidosis
nivolumab|seborrheic dermatitis
nivolumab|sepsis
nivolumab|sinusitis
nivolumab|skin reaction
nivolumab|small intestine obstruction
nivolumab|spinal pain
nivolumab|spondyloarthropathy
nivolumab|steroid-requiring febrile syndrome
nivolumab|stevens-johnson syndrome
nivolumab|stomatitis
nivolumab|systemic inflammatory response syndrome
nivolumab|thrombocytopenia
nivolumab|thyroiditis
nivolumab|thyroxine decreased
nivolumab|thyroxine free increased
nivolumab|thyroxine increased
nivolumab|toxic epidermal necrolysis
nivolumab|tri-iodothyronine free increased
nivolumab|tri-iodothyronine increased
nivolumab|type 1 diabetes mellitus
nivolumab|upper abdominal pain
nivolumab|upper respiratory infection
nivolumab|upper respiratory tract infection
nivolumab|urinary tract infection
nivolumab|uveitis
nivolumab|vasculitis
nivolumab|ventricular arrhythmia
nivolumab|vesicular rash
nivolumab|viral rhinitis
nivolumab|viral uri
nivolumab|vitiligo
nivolumab|vomiting
nivolumab|weight decreased